End-of-day quote
Other stock markets
|
||
- HKD | - |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Sales 2024 * | 3.08B 24.11B | Sales 2025 * | 3.92B 30.67B | Capitalization | 15.06B 118B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.98B | Net income 2025 * | -358M -2.8B | EV / Sales 2024 * | 4.41 x |
Net cash position 2024 * | 1.48B 11.6B | Net cash position 2025 * | 1.13B 8.85B | EV / Sales 2025 * | 3.55 x |
P/E ratio 2024 * |
-16.9
x | P/E ratio 2025 * |
-39.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
+5.47% | 14.09B | |
+28.85% | 10.99B | |
-24.93% | 8.63B |